Evidence map›Paper›PMID 25311173›Full record

ReviewSeminars in perinatology2014

Pharmacological management of hypertension in pregnancy.

Thomas R Easterling

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in perinatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Treating Hypertension in Pregnancy.Current hypertension reports · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas R EasterlingDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195. Electronic address: easter@u.washington.edu.
University of Washington · US

Funding

UW Obstetric-Fetal Pharmacology Research UnitU10HD047892 · NICHD · UNIVERSITY OF WASHINGTON · PI EASTERLING, THOMAS R, HEBERT, MARY F · 2004 to 2014
$9.4M
NICHD NIH HHS U10 HD047892NICHD NIH HHS U10-HD047892
6 · The paper itself

Abstract

Hypertension in pregnancy remains a significant public health problem. Pharmacological management of blood pressure in pregnancy is impacted by changes in maternal drug disposition and by the pharmacodynamic effects of specific agents. This article will review the impact of pregnancy on pathways of drug elimination and the associated clinical implications, the pharmacodynamic effects of specific drugs and classes of drugs in pregnancy, and the data to date on the impact of antihypertensive therapy on mothers and their fetuses.

Indexed as

Adrenergic alpha-AgonistsAdrenergic beta-AntagonistsAntihypertensive AgentsCalcium Channel BlockersDiureticsFemaleHumansHypertensionHypertension, Pregnancy-InducedPregnancyPregnancy Complications, CardiovascularVasodilator AgentsAdrenergic alpha-AgonistsAdrenergic beta-AntagonistsAntihypertensive AgentsCalcium Channel BlockersDiureticsVasodilator AgentsantihypertensivehypertensionIUGRpreeclampsiapregnancy

Identifiers

PMID25311173
PMCPMC4272602
OpenAlexW2049990270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.